Drugs / Closone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01765452 | Oct 2012 → Aug 2013 | coronary artery disorder | HK inno.N Corporation | Completed | No outcome recorded |
| Phase 4 | NCT01763749 | Oct 2012 → Oct 2014 | coronary artery disorder | Seoul St. Mary's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Closone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01763749 ↗ |
| Route | Oral | “Closone 75mg/100mg, 4weeks, PO” NCT01763749 ↗ |